Relay Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Relay Therapeutics

23/02/2023 23:34

* Relay Therapeutics Inc  RLAY.OQ  reported quarterly
adjusted
earnings of 56 cents​​ per share for the quarter ended in
December. The mean expectation of ten analysts for the quarter
was for a loss of 70 cents per share.
    * Revenue fell 55.4% to $253.00 thousand from a year ago;
analysts
expected $3.30 million. 
    * Relay Therapeutics Inc's reported EPS for the quarter was
56
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Relay Therapeutics Inc shares had risen by 18.5% this
quarter.
    * The company reported a quarterly loss of $67.5 million.
    * Wall Street's median 12-month price target for Relay
Therapeutics Inc is $38.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
23 at 11:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.70          0.56           Beat
 Sep. 30 2022      -0.71          -0.76          Missed
 Jun. 30 2022      -0.63          -0.71          Missed
 Mar. 31 2022      -0.62          -0.57          Beat